Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer
NCT02202655 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2014-07-29
Summary
The purpose of this study is to investigate the changes of lymphocyte subsets in chemotherapy course of patients with non-small cell lung cancer
Conditions
Sponsors & Collaborators
-
Beijing Chao Yang Hospital
lead OTHER
Principal Investigators
-
yingmin ma · Vice President of the Beijing chaoyang hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-09-30
Countries
- China
Study Locations
More Related Trials
-
Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
NCT07256002 ·Status: ACTIVE_NOT_RECRUITING
-
Neoadjuvant Immunochemotherapy for Lung Cancer
NCT06023797 ·Status: COMPLETED
-
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
NCT05636605 ·Status: RECRUITING
-
Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer
NCT06907160 ·Status: RECRUITING
-
irAE Prediction of Anti-PD-1/L1 in Lung Cancer
NCT05288569 ·Status: UNKNOWN
-
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
NCT05415358 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
NCT07035860 ·Status: NOT_YET_RECRUITING
-
Prediction Model of ICIs Combined With Chemotherapy in Advanced NSCLC
NCT05725915 ·Status: UNKNOWN
-
Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy
NCT02821949 ·Status: UNKNOWN
-
Immune-Marker Platform for Patients With Advanced Lung Cancer
NCT07150598 ·Status: NOT_YET_RECRUITING
-
Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer
NCT04266691 ·Status: COMPLETED
-
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
NCT04040244 ·Status: TERMINATED ·Phase: NA
-
Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator
NCT04352335 ·Status: COMPLETED
-
A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
NCT06503042 ·Status: NOT_YET_RECRUITING
-
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
NCT04229121 ·Status: UNKNOWN
-
Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer
NCT01551251 ·Status: COMPLETED
-
Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer
NCT04187768 ·Status: COMPLETED
-
Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC
NCT05637580 ·Status: COMPLETED
-
Dynamic Circulating Tumor Cell (CTC) Changes During the Chemotherapy in NSCLC
NCT01740804 ·Status: COMPLETED
-
Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer
NCT05252065 ·Status: UNKNOWN
-
Prospective Observation of Failure Patterns in NSCLC Treated With ICIs
NCT04492969 ·Status: UNKNOWN
-
Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer
NCT02320617 ·Status: UNKNOWN ·Phase: NA
-
Integrative Multi-Omics Testing for Immunotherapy Response in Non-Small Cell Lung Cancer
NCT05928299 ·Status: COMPLETED
-
Prognostic and Dynamic Change of CTC Enumeration in Advanced NSCLC With Chemotherapy and Targeted Therapy
NCT02155426 ·Status: UNKNOWN
-
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
NCT05066945 ·Status: NOT_YET_RECRUITING